Experienced Firm Helping Victims of Weight Loss Balloon Treatment
The U.S. Food and Drug Administration (FDA) has issued several alerts to healthcare providers to report the deaths of patients with liquid-filled intragastric balloon systems. In these communications, the FDA has urged doctors to closely monitor these patients for the risk of life-threatening complications, including pancreatitis and spontaneous over-inflation. Since 2016, the FDA has received reports of a total of 12 deaths that occurred in patients with liquid-filled intragastric balloon